Unichem Laboratories Limited

NSE UNICHEMLAB.NS

Unichem Laboratories Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2024: USD -12.75 M

Unichem Laboratories Limited Net Cash Used Provided By Financing Activities is USD -12.75 M for the year ending March 31, 2024, a -28.85% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Unichem Laboratories Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2023 was USD -9.89 M, a -139.28% change year over year.
Unichem Laboratories Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2022 was USD 25.18 M, a 252.16% change year over year.
Unichem Laboratories Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2021 was USD -16.55 M, a -100.20% change year over year.
Unichem Laboratories Limited Net Cash Used Provided By Financing Activities for the year ending March 31, 2020 was USD -8.27 M, a -2,278.71% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

NSE: UNICHEMLAB.NS

Unichem Laboratories Limited

CEO	Mr. Scott B. Delaney
IPO Date	July 1, 2002
Location	India
Headquarters	Unichem Bhavan
Employees	2,875
Sector	Health Care
Industries Pharmaceuticals

Description

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company was founded in 1944 and is headquartered in Mumbai, India.

Key trends

Past 5 years